Human microbiomes in cancer development and therapy

Abstract Colonies formed by bacteria, archaea, fungi, and viral groups and their genomes, metabolites, and expressed proteins constitute complex human microbiomes. An increasing evidences showed that carcinogenesis and disease progression were link to microbiomes. Different organ sources, their micr...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenglai Xia, Jiyan Su, Can Liu, Zhikai Mai, Shuanghong Yin, Chuansheng Yang, Liwu Fu
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.221
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589927551860736
author Chenglai Xia
Jiyan Su
Can Liu
Zhikai Mai
Shuanghong Yin
Chuansheng Yang
Liwu Fu
author_facet Chenglai Xia
Jiyan Su
Can Liu
Zhikai Mai
Shuanghong Yin
Chuansheng Yang
Liwu Fu
author_sort Chenglai Xia
collection DOAJ
description Abstract Colonies formed by bacteria, archaea, fungi, and viral groups and their genomes, metabolites, and expressed proteins constitute complex human microbiomes. An increasing evidences showed that carcinogenesis and disease progression were link to microbiomes. Different organ sources, their microbial species, and their metabolites are different; the mechanisms of carcinogenic or procancerous are also different. Here, we summarize how microbiomes contribute to carcinogenesis and disease progression in cancers of the skin, mouth, esophagus, lung, gastrointestinal, genital, blood, and lymph malignancy. We also insight into the molecular mechanisms of triggering, promoting, or inhibiting carcinogenesis and disease progress induced by microbiomes or/and their secretions of bioactive metabolites. And then, the strategies of application of microorganisms in cancer treatment were discussed in detail. However, the mechanisms by which human microbiomes function are still poorly understood. The bidirectional interactions between microbiotas and endocrine systems need to be clarified. Probiotics and prebiotics are believed to benefit human health via a variety of mechanisms, in particular, in tumor inhibition. It is largely unknown how microbial agents cause cancer or how cancer progresses. We expect this review may open new perspectives on possible therapeutic approaches of patients with cancer.
format Article
id doaj-art-9bf24271a5a644bf9d87fd87bfedeccd
institution Kabale University
issn 2688-2663
language English
publishDate 2023-04-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-9bf24271a5a644bf9d87fd87bfedeccd2025-01-24T05:36:29ZengWileyMedComm2688-26632023-04-0142n/an/a10.1002/mco2.221Human microbiomes in cancer development and therapyChenglai Xia0Jiyan Su1Can Liu2Zhikai Mai3Shuanghong Yin4Chuansheng Yang5Liwu Fu6Affiliated Foshan Maternity and Chlid Healthcare Hospital Southern Medical University, Foshan, China; School of Pharmaceutical Sciences, Southern Medical University Guangzhou ChinaAffiliated Foshan Maternity and Chlid Healthcare Hospital Southern Medical University, Foshan, China; School of Pharmaceutical Sciences, Southern Medical University Guangzhou ChinaAffiliated Foshan Maternity and Chlid Healthcare Hospital Southern Medical University, Foshan, China; School of Pharmaceutical Sciences, Southern Medical University Guangzhou ChinaAffiliated Foshan Maternity and Chlid Healthcare Hospital Southern Medical University, Foshan, China; School of Pharmaceutical Sciences, Southern Medical University Guangzhou ChinaAffiliated Foshan Maternity and Chlid Healthcare Hospital Southern Medical University, Foshan, China; School of Pharmaceutical Sciences, Southern Medical University Guangzhou ChinaDepartment of Head‐Neck and Breast Surgery Yuebei People's Hospital of Shantou University Shaoguan ChinaState Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine; Guangdong Esophageal Cancer Institute; Sun Yat‐sen University Cancer Center Guangzhou People's Republic of ChinaAbstract Colonies formed by bacteria, archaea, fungi, and viral groups and their genomes, metabolites, and expressed proteins constitute complex human microbiomes. An increasing evidences showed that carcinogenesis and disease progression were link to microbiomes. Different organ sources, their microbial species, and their metabolites are different; the mechanisms of carcinogenic or procancerous are also different. Here, we summarize how microbiomes contribute to carcinogenesis and disease progression in cancers of the skin, mouth, esophagus, lung, gastrointestinal, genital, blood, and lymph malignancy. We also insight into the molecular mechanisms of triggering, promoting, or inhibiting carcinogenesis and disease progress induced by microbiomes or/and their secretions of bioactive metabolites. And then, the strategies of application of microorganisms in cancer treatment were discussed in detail. However, the mechanisms by which human microbiomes function are still poorly understood. The bidirectional interactions between microbiotas and endocrine systems need to be clarified. Probiotics and prebiotics are believed to benefit human health via a variety of mechanisms, in particular, in tumor inhibition. It is largely unknown how microbial agents cause cancer or how cancer progresses. We expect this review may open new perspectives on possible therapeutic approaches of patients with cancer.https://doi.org/10.1002/mco2.221cancer therapycarcinogenesismicrobiomemicroorganismtumor
spellingShingle Chenglai Xia
Jiyan Su
Can Liu
Zhikai Mai
Shuanghong Yin
Chuansheng Yang
Liwu Fu
Human microbiomes in cancer development and therapy
MedComm
cancer therapy
carcinogenesis
microbiome
microorganism
tumor
title Human microbiomes in cancer development and therapy
title_full Human microbiomes in cancer development and therapy
title_fullStr Human microbiomes in cancer development and therapy
title_full_unstemmed Human microbiomes in cancer development and therapy
title_short Human microbiomes in cancer development and therapy
title_sort human microbiomes in cancer development and therapy
topic cancer therapy
carcinogenesis
microbiome
microorganism
tumor
url https://doi.org/10.1002/mco2.221
work_keys_str_mv AT chenglaixia humanmicrobiomesincancerdevelopmentandtherapy
AT jiyansu humanmicrobiomesincancerdevelopmentandtherapy
AT canliu humanmicrobiomesincancerdevelopmentandtherapy
AT zhikaimai humanmicrobiomesincancerdevelopmentandtherapy
AT shuanghongyin humanmicrobiomesincancerdevelopmentandtherapy
AT chuanshengyang humanmicrobiomesincancerdevelopmentandtherapy
AT liwufu humanmicrobiomesincancerdevelopmentandtherapy